Glimemag PM 2mg/500mg/15mg Tablet
Marketer
Magma Allianz Laboratories Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimemag PM 2mg/500mg/15mg Tablet
Glimepiride/Metformin/Pioglitazone 2mg/500mg/15mg tablets are a triple-combination medication managing blood glucose. This medication, used alongside diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It optimizes insulin utilization, resulting in reduced blood sugar. Adhere strictly to your physician's prescribed dosage and regimen. Take this medication with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly; however, near the next scheduled dose, omit the missed dose and resume the usual schedule. Never double the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other antidiabetic agents, alcohol, or skipped meals increases the hypoglycemia risk. Regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Before commencing treatment, inform your doctor about any kidney, liver, or heart conditions. Pregnant or lactating individuals should consult their physician prior to use. Kidney function tests will be conducted before therapy begins. Limit alcohol consumption as it may heighten the risk of side effects.
Uses of Glimemag PM 2mg/500mg/15mg Tablet
Managing Type 2 Diabetes
Major Benefits of Glimemag PM 2mg/500mg/15mg Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimemag PM 2mg/500mg/15mg Tablet should be administered with a meal.
Common Side effects of Glimemag PM 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimemag PM 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimemag PM 2mg/500mg/15mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Glimemag PM 2mg/500mg/15mg Tablet works:
Glimemag PM 2mg/500mg/15mg tablets contain glimepiride, metformin, and pioglitazone, three antidiabetic agents with distinct actions. This triple combination improves blood sugar management when single or dual drug therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further boosts insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Glimemag PM 2mg/500mg/15mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Using Glimemag PM 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against any possible dangers prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimemag PM 2mg/500mg/15mg tablets while breastfeeding is likely unsafe. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glimemag PM 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimemag PM 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. The use of Glimemag PM 2mg/500mg/15mg tablets is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimemag PM 2mg/500mg/15mg Tablet :
Should you forget a Glimemag PM 2mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimemag PM 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently